AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.67 |
Market Cap | 5.30M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 287.92 |
PE Ratio (ttm) | 0.01 |
Forward PE | n/a |
Analyst | Buy |
Ask | 1.69 |
Volume | 48,874 |
Avg. Volume (20D) | 802,521 |
Open | 1.68 |
Previous Close | 1.67 |
Day's Range | 1.66 - 1.74 |
52-Week Range | 1.65 - 15.79 |
Beta | undefined |
About TNON
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California....
Analyst Forecast
According to 2 analyst ratings, the average rating for TNON stock is "Buy." The 12-month stock price forecast is $16, which is an increase of 847.14% from the latest price.
Next Earnings Release
Analysts project revenue of $1.53M, reflecting a 89.36% YoY growth and earnings per share of -3.13, making a -42.46% decrease YoY.